You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

DMR

Showing 1 - 25 of 221
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Diabetes, Type 2 Trial (Revita® DMR Treatment, Sham procedure)

Not yet recruiting
  • Diabetes Mellitus, Type 2
  • Revita® DMR Treatment
  • Sham procedure
  • (no location specified)
Oct 18, 2023

Degenerative Mitral Valve Disease Trial in Beijing (NovoClasp® transcatheter mitral valve clip and steerable guide catheter)

Active, not recruiting
  • Degenerative Mitral Valve Disease
  • NovoClasp® transcatheter mitral valve clip and steerable guide catheter
  • Beijing, China
    Beijing Anzhen Hospital, Capital Medical University
Aug 28, 2023

Type 2 Diabetes Trial in United States (Duodenal Mucosal Resurfacing (DMR), Duodenal Mucosal Resurfacing Sham (Sham))

Completed
Has Results
  • Type 2 Diabetes
  • Duodenal Mucosal Resurfacing (DMR)
  • Duodenal Mucosal Resurfacing Sham (Sham)
  • Orlando, Florida
  • +5 more
Jun 30, 2022

Diabetes, Type 2, Noninsulin-Dependent Diabetes Trial in Worldwide (DMR Procedure, Sham Procedure)

Completed
Has Results
  • Diabetes Mellitus, Type 2
  • Noninsulin-Dependent Diabetes Mellitus
  • DMR Procedure
  • Sham Procedure
  • Brussels, Belgium
  • +10 more
Apr 30, 2021

NASH - Nonalcoholic Steatohepatitis Trial in Brussels (DMR)

Completed
  • NASH - Nonalcoholic Steatohepatitis
  • DMR
  • Brussels, Belgium
    Erasme Hospital
Feb 24, 2021

Degenerative Mitral Valve Disease Trial in Hangzhou (Dragonfly Transcatheter Mitral Valve Repair System)

Enrolling by invitation
  • Degenerative Mitral Valve Disease
  • Dragonfly Transcatheter Mitral Valve Repair System
  • Hangzhou, Zhejiang, China
    The Second Affiliated Hospital Zhejiang University School of Med
Jun 9, 2021

Degenerative Mitral Valve Disease Trial (Transcatheter mitral valve repair (PLAR Implant and Delivery System))

Not yet recruiting
  • Degenerative Mitral Valve Disease
  • Transcatheter mitral valve repair (PLAR Implant and Delivery System)
  • (no location specified)
Dec 21, 2020

Cellulite Trial in Westport (Qwo)

Completed
  • Cellulite
  • Westport, Connecticut
    DMR Research, PLLC
Sep 16, 2021

Vitiligo Trial in United States (Spray-On Skin™ Cells 1:20 followed by NB-UVB, NB-UVB only)

Active, not recruiting
  • Vitiligo
  • Spray-On Skin™ Cells 1:20 followed by NB-UVB
  • NB-UVB only
  • Irvine, California
  • +11 more
Dec 14, 2022

Degenerative Mitral Valve Disease Trial (Transcatheter mitral valve repair)

Not yet recruiting
  • Degenerative Mitral Valve Disease
  • Transcatheter mitral valve repair
  • (no location specified)
Dec 7, 2020

Glabellar Lines Trial in Canada, United States (AGN-151586, Placebo)

Recruiting
  • Glabellar Lines
  • Scottsdale, Arizona
  • +16 more
Aug 15, 2022

Platysma Prominence Trial in Canada, United States (BOTOX)

Active, not recruiting
  • Platysma Prominence
  • Glendale, Arizona
  • +28 more
Jan 6, 2023

Diabetes, Type 2, Diabetes Trial in Worldwide (DMR Procedure (Fractyl))

Completed
  • Diabetes Mellitus, Type 2
  • Diabetes Mellitus
  • DMR Procedure (Fractyl)
  • Brussels, Belgium
  • +6 more
Jun 3, 2020

Treatment Free Remission (TFR) in CML Patients (CML-CP)Study

Not yet recruiting
  • Chronic Myeloid Leukemia
  • Treatment-free Remission
  • TFR(Treatment-Free Remission)
  • (no location specified)
Jun 27, 2022

Action of Interferon in Treatment of Myeloproliferative

Recruiting
  • Myeloproliferative Neoplasm
    • Villejuif, Ile De France, France
      Inserm U1287
    Apr 28, 2023

    Retrospective Observational Cohort Study of SYMBOL CUP DM 2

    Completed
    • Revision Total Hip Arthroplasty
    • Primary Total Hip Arthroplasty
    • THA with SYMBOL CUP DMR HA
    • THA with SYMBOL CUP DM CEM
    • Challes les Eaux, France
      Hôpital Privé Medipole de Savoie
    Dec 25, 2019

    Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission Trial (Asciminib, Imatinib)

    Not yet recruiting
    • Chronic Myeloid Leukemia, BCR/ABL-Positive, in Remission
    • (no location specified)
    Jun 7, 2022

    Platysma Prominence Trial in Canada, United States (OnabotulinumtoxinA, Placebo)

    Recruiting
    • Platysma Prominence
    • Glendale, Arizona
    • +29 more
    Dec 29, 2021

    Mitral Regurgitation Trial in United States (HARPOON™ Beating Heart Mitral Valve Repair System)

    Recruiting
    • Mitral Regurgitation
    • HARPOON™ Beating Heart Mitral Valve Repair System
    • Birmingham, Alabama
    • +29 more
    Aug 23, 2022

    Mitral Valve Insufficiency Trial (DragonFly Transcatheter Mitral Valve Repair System)

    Not yet recruiting
    • Mitral Valve Insufficiency
    • DragonFly Transcatheter Mitral Valve Repair System
    • (no location specified)
    Jun 30, 2023

    Premature Loss of Primary Teeth Trial in Ismailia (lower lingual holding arch space maintainer, Removable partial denture space

    Not yet recruiting
    • Premature Loss of Primary Teeth
    • lower lingual holding arch space maintainer
    • Removable partial denture space maintainer
    • Ismailia, Egypt
      Faculty of medicine, Suez Canal University
    Nov 17, 2023

    Surgical and Percutaneous Double Orefices Mitral Repair in p2

    Completed
    • Degenerative Mitral Valve Disease
    • Mitral Regurgitation
    • Central edge-to-edge
    • Milan, Italy
      IRCCS Ospedale San Raffaele - Cardiac Surgery Department
    Apr 28, 2023

    Chronic Myeloid Leukemia Trial in Worldwide

    Recruiting
    • Chronic Myeloid Leukemia
      • Montréal, Quebec, Canada
      • +25 more
      Jul 25, 2022

      Mitral Valve Regurgitation Trial

      Not yet recruiting
      • Mitral Valve Regurgitation
        • (no location specified)
        Jul 15, 2022

        Sedation, Intubation Trial in Guangzhou (dexmedetomidine combined with midazolam and remifentanil., propofol combined with

        Completed
        • Sedation
        • Intubation
        • dexmedetomidine combined with midazolam and remifentanil.
        • propofol combined with midazolam and remifentanil.
        • Guangzhou, Guangdong, China
          the Sixth Affiliated Hospital, Sun Yat-sen University
        Nov 28, 2022